source
- Percutaneous Catheter Recall: Boston Scientific Removes ENROUTE Transcarotid Neuroprotection SystemENROUTE Transcarotid Neuroprotection Systems may have arterial sheath tip separation or partial tip separation during use.fda medwatch · 19h ago↗ source
- FDA expands Jazz's Ziihera to frontline HER2-positive gastroesophageal cancers, unlocking $1.5 billion marketThe U.S. Food and Drug Administration has broadened the approved use of Jazz Pharmaceuticals' cancer therapy Ziihera. The drug can now be given as an initial treatment for patients with HER2‑positi…